Zoetis (WBO:ZOTS) Total Liabilities : €8,552 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Zoetis Total Liabilities?

Zoetis's Total Liabilities for the quarter that ended in Mar. 2024 was €8,552 Mil.

Zoetis's quarterly Total Liabilities increased from Sep. 2023 (€8,462.98 Mil) to Dec. 2023 (€8,523.52 Mil) and increased from Dec. 2023 (€8,523.52 Mil) to Mar. 2024 (€8,552.32 Mil).

Zoetis's annual Total Liabilities increased from Dec. 2021 (€8,280.06 Mil) to Dec. 2022 (€9,932.77 Mil) but then declined from Dec. 2022 (€9,932.77 Mil) to Dec. 2023 (€8,523.52 Mil).

Zoetis Total Liabilities Historical Data

The historical data trend for Zoetis's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Total Liabilities Chart

Zoetis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

7,953.30

8,085.19

8,280.06

9,932.77

8,523.52

Zoetis Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															8,651.64	8,425.14	8,462.98	8,523.52	8,552.32

Zoetis Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Zoetis's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1732.213	+	(6191.584	+	465.836
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	133.882	+	0)
	=	8,524

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	13100.262	-	4576.747
	=	8,524

Zoetis's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1756.28	+	(6206.32	+	464.6
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	125.12	+	0)
	=	8,552

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	13200.16	-	4647.84
	=	8,552

Zoetis Total Liabilities Related Terms

Thank you for viewing the detailed overview of Zoetis's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Zoetis (WBO:ZOTS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (WBO:ZOTS) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

ZTS:USA ZTS:Mexico 1ZTS:Italy ZOE:Germany Z1TS34:Brazil

Address

10 Sylvan Way, Parsippany, NJ, USA, 07054

Website

https://www.zoetis.com

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Zoetis (WBO:ZOTS) Headlines

No Headlines